Effect of Video Viewing on Intravitreal Injection Experience

Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Study ID
NCT07002372
Status
Recruiting
Apply to this trial

Conditions

  • Age Related Macular Degeneration
  • Choroidal Neovascularization
  • Cystoid Macular Edema
  • Diabetic Retinopathy
  • Retinal Vein Occlusion

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Procedure video viewing — BEHAVIORAL
    Patients who have never had an intravitreal injection before will be randomly assigned to watch an educational video about the procedure prior to treatment.

Study Details

Study Objective The goal of this clinical trial is to evaluate whether viewing a procedural video can improve the patient experience and reduce the incidence and severity of subconjunctival hemorrhage in individuals undergoing intravitreal anti-VEGF injections. Key Research Questions 1. Can viewing the procedural video prior to treatment reduce the rate and/or area of subconjunctival hemorrhage? 2. Can the video improve the patient experience, specifically by reducing anxiety levels and increasing satisfaction with the treatment process? Study Design Participants will be randomly assigned to either an intervention group, who will watch an educational video explaining the injection procedure, or a control group, who will not view the video. All participants will complete the State-Trait Anxiety Inventory-State (STAI-S) questionnaire both before and after treatment to assess changes in anxiety levels.

Key Dates

First listed
Jun 3, 2025
Start date
May 5, 2025
Status verified
May 2025
Primary completion
Aug 5, 2025
Completion
Oct 5, 2025

Study Design

Enrollment
182 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Arms

  • Experimental: Procedural video viewing Group
    Participants will watch an educational video explaining the injection procedure prior to treatment.
  • No Intervention: Control Group
    Participants will not view the video before the treatment.

Primary Outcome Measure

Rate and area of subconjunctival hemorrhage [ Time Frame: 3 minutes after the intravitreal injection procedure. ]

Central Contacts

Find similar trials

Nationwide
Diabetic retinopathy trialsOphthalmology trialsRetina trials

Related Studies